Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 10/20 | 0.53 |
| ▸ | MAOB | P27338 | 10/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | PRKCI | P41743 | 1/20 | 0.51 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.46 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32691764 | 1.00 | GRM5 (0.55) | GRM5MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL19685911 | 0.89 | HSD17B1 (0.61) | GRM5MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL19686133 | 0.87 | MAOA (0.53) | GRM5MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL17361577 | 0.84 | GRM5 (0.52) | GRM5MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL19686129 | 0.82 | GRM5 (0.42) | GRM5MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL19686137 | 0.80 | MAOA (0.49) | GRM5MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL8852754 | 0.79 | ALDH1A1 (0.43) | MEN1MAPK1KMT2A | |
| SCHEMBL11872289 | 0.78 | MAOB (0.56) | GRM5MAOAMAOBCYP2A6PRKCI | |
| SCHEMBL29282570 | 0.77 | MAOB (0.51) | GRM5MAOAMAOBCYP2A6PRKCI | |
| Hydrochloric Acid SCHEMBL11463421 | 0.77 | MAOB (0.54) | GRM5MAOAMAOBCYP2A6PRKCI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | CYC1, CCNA1, CYCS | GRM5 4529/4885MAOA 1632/4885MAOB 1878/4885 |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | CYC1, CCNA1, CYCS | GRM5 4529/4885MAOA 1632/4885MAOB 1878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.